• Out-of-Stock

TruSight RNA Fusion Panel

Provides comprehensive gene fusion detection in formalin-fixed, paraffin-embedded (FFPE) and other cancer research samples.
Sorry, This item is out of stock.

  Security policy

(edit with the Customer Reassurance module)

  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

(edit with the Customer Reassurance module)

Product Highlights

This targeted RNA sequencing panel is a cost-effective solution to detect gene fusions in multiple cancer types, regardless of origin. Covering 507 fusion-associated genes, a single assay enables researchers to assess most known cancer-related fusions in blood, bone marrow, and FFPE samples, with the power to identify novel fusion gene partners.

  • Industry-validated content for a comprehensive view of cancer-related fusion genes, detecting common and novel fusions
  • From RNA to results in 4 days including on-instrument software that displays fusion calls
  • Compatibility with desktop sequencers to maximize lab budgets
  • Optimized RNA sequencing for all sample types, including FFPE tissues
Simple Fusion Report for Customers New to NGS

On-instrument fusion calling provides NGS-based fusion detection to labs without additional bioinformatics support. The analysis provides a list of detected fusions, relevant disease associations (as identified by the Mitelman database), and evidence of fusion-supporting reads.

Robust, Reproducible, and Low-Input Fusion Assay

This assay accommodates as little input as 20 ng FFPE RNA or 10 ng fresh-frozen total RNA. The TruSight RNA Fusion Panel provides a sensitive, reproducible, and economical solution for studies of gene fusions in cancer research.






TruSight RNA Fusion Panel Data Sheet | PDF(< 1 MB)

TruSight RNA Fusion Panel Gene List product_file | EXCEL(< 1 MB)


Visit  illumina logo  Web Site...



Comments (0)
No customer reviews for the moment.